Clinical trial: A PHASE III, OPEN-LABEL, SINGLE-ARM, MULTI-CENTER STUDY TO EVALUATE THE SAFETY AND USE OF AN ON-BODY DELIVERY SYSTEM FOR THE SUBCUTANEOUS HOME ADMINISTRATION OF OCRELIZUMAB IN PATIENTS WITH MULTIPLE SCLEROSIS

https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2025-523726-40-00?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_24348

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology